1887

Abstract

Epstein–Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) consists of W1W2 repeats and a unique C-terminal Y1Y2 domain and plays a critical role in EBV-induced transformation. To identify the cellular proteins associating with EBNA-LP, we performed a yeast two-hybrid screen using EBNA-LP cDNA containing a single W1W2 domain as bait and an EBV-transformed human peripheral blood lymphocyte cDNA library as the source of cellular genes. Our results were as follows. (i) A cDNA in the positive yeast colony was found to encode a cellular protein, human oestrogen-related receptor 1 (hERR1), which is a constitutive transcriptional activator of the various types of oestrogen response elements. (ii) A purified chimeric protein consisting of glutathione -transferase (GST) fused to hERR1 specifically formed complexes with EBNA-LPs containing one (EBNA-LPR1), two (EBNA-LPR2) or four W1W2 repeats (EBNA-LPR4) transiently expressed in COS-7 cells. Reciprocally, GST fused to EBNA-LPR1 or EBNA-LPR2 pulled down hERR1 transiently expressed in COS-7 cells. (iii) Mutational analyses of EBNA-LP revealed that the Y2 domain of EBNA-LP is responsible for the interaction with hERR1 and two leucines in the Y2 domain (Leu-78 and -82), which are conserved among a subset of primate gammaherpesviruses, are interactive sites for hERR1. So far, it has been reported that the only domain of EBNA-LP critical for EBV-induced transformation is the Y1Y2 domain. Potential roles of hERR1 in EBV-induced transformation are discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18615-0
2003-02-01
2019-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/2/vir840319.html?itemId=/content/journal/jgv/10.1099/vir.0.18615-0&mimeType=html&fmt=ahah

References

  1. Alfieri, C., Birkenbach, M. & Kieff, E. ( 1991; ). Early events in Epstein–Barr virus infection of human B lymphocytes. Virology 181, 595–608.[CrossRef]
    [Google Scholar]
  2. Allan, G. J., Inman, G. J., Parker, B. D., Rowe, D. T. & Farrell, P. J. ( 1992; ). Cell growth effects of Epstein–Barr virus leader protein. J Gen Virol 73, 1547–1551.[CrossRef]
    [Google Scholar]
  3. Andersen, J. H., Osbakk, S. A., Vorland, L. H., Traavik, T. & Gutteberg, T. J. ( 2001; ). Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51, 141–149.[CrossRef]
    [Google Scholar]
  4. Bandobashi, K., Maeda, A., Teramoto, N., Nagy, N., Szekely, L., Taguchi, H., Miyoshi, I., Klein, G. & Klein, E. ( 2001; ). Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes. Virology 288, 275–282.[CrossRef]
    [Google Scholar]
  5. Bonnelye, E., Vanacker, J. M., Dittmar, T., Begue, A., Desbiens, X., Denhardt, D. T., Aubin, J. E., Laudet, V. & Fournier, B. ( 1997a; ). The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. Mol Endocrinol 11, 905–916.[CrossRef]
    [Google Scholar]
  6. Bonnelye, E., Vanacker, J. M., Spruyt, N., Alric, S., Fournier, B., Desbiens, X. & Laudet, V. ( 1997b; ). Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development. Mech Dev 65, 71–85.[CrossRef]
    [Google Scholar]
  7. Chen, S., Zhou, D., Okubo, T., Kao, Y. C. & Yang, C. ( 1999; ). Breast tumor aromatase: functional role and transcriptional regulation. Endocr Relat Cancer 6, 149–156.[CrossRef]
    [Google Scholar]
  8. Giguere, V., Yang, N., Segui, P. & Evans, R. M. ( 1998; ). Identification of a new class of steroid hormone receptors. Nature 331, 91–94.
    [Google Scholar]
  9. Hammerschmidt, W. & Sugden, B. ( 1989; ). Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes. Nature 340, 393–397.[CrossRef]
    [Google Scholar]
  10. Han, I., Harada, S., Weaver, D., Xue, Y., Lane, W., Orstavik, S., Skalhegg, B. & Kieff, E. ( 2001; ). EBNA-LP associates with cellular proteins including DNA-PK and HA95. J Virol 75, 2475–2481.[CrossRef]
    [Google Scholar]
  11. Harada, S. & Kieff, E. ( 1997; ). Epstein–Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 71, 6611–6618.
    [Google Scholar]
  12. Hutchens, T. W. & Lonnerdal, B. ( 1997; ). Lactoferrin: Interaction and Biological Functions, pp. 3–23. Totowa, NJ: Humana Press.
    [Google Scholar]
  13. Jiang, W. Q., Szekely, L., Wendel-Hansen, V., Ringertz, N., Klein, G. & Rosen, A. ( 1991; ). Co-localization of the retinoblastoma protein and the Epstein–Barr virus-encoded nuclear antigen EBNA-5. Exp Cell Res 197, 314–318.[CrossRef]
    [Google Scholar]
  14. Kawaguchi, Y., Tomonaga, K., Maeda, K., Ono, M., Miyazawa, T., Kohmoto, M., Tohya, Y. & Mikami, T. ( 1995; ). The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4. Virology 208, 492–499.[CrossRef]
    [Google Scholar]
  15. Kawaguchi, Y., Bruni, R. & Roizman, B. ( 1997a; ). Interaction of herpes simplex virus 1 α regulatory protein ICP0 with elongation factor 1δ: ICP0 affects translational machinery. J Virol 71, 1019–1024.
    [Google Scholar]
  16. Kawaguchi, Y., Bruni, R. & Roizman, B. ( 1997b; ). Herpes simplex virus 1 α regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 71, 7328–7336.
    [Google Scholar]
  17. Kawaguchi, Y., Nakajima, K., Igarashi, M. & 8 other authors. ( 2000; ). Interaction of Epstein–Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol 74, 10104–10111.[CrossRef]
    [Google Scholar]
  18. Kieff, E. ( 1996; ). Epstein–Barr Virus and its replication. In Fields Virology, 3rd edn, pp. 2343–2396. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott–Raven.
    [Google Scholar]
  19. Kieff, E. & Rickinson, A. B. ( 2001; ). Epstein–Barr virus and its replication. In Fields Virology, 4th edn, pp. 2511–2574. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
    [Google Scholar]
  20. Kitay, M. K. & Rowe, D. T. ( 1996; ). Protein–protein interactions between Epstein–Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins. Virology 220, 91–99.[CrossRef]
    [Google Scholar]
  21. Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A. & Kieff, E. ( 1991; ). The Epstein–Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65, 6826–6837.
    [Google Scholar]
  22. Mannick, J. B., Tong, X., Hemnes, A. & Kieff, E. ( 1995; ). The Epstein–Barr virus nuclear antigen leader protein associates with hsp72/hsc73. J Virol 69, 8169–8172.
    [Google Scholar]
  23. McCann, E. M., Kelly, G. L., Rickinson, A. B. & Bell, A. I. ( 2001; ). Genetic analysis of the Epstein–Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function. J Gen Virol 82, 3067–3079.
    [Google Scholar]
  24. Mori, Y., Dhepakson, P., Shimamto, T., Ueda, K., Gomi, Y., Tani, H., Matsuura, Y. & Yamanishi, K. ( 2000; ). Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo. J Virol 74, 6096–6104.[CrossRef]
    [Google Scholar]
  25. Nitsche, F., Bell, A. & Rickinson, A. ( 1997; ). Epstein–Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. J Virol 71, 6619–6628.
    [Google Scholar]
  26. Peng, R., Gordadze, A. V., Fuentes Panana, E. M., Wang, F., Zong, J., Hayward, G. S., Tan, J. & Ling, P. D. ( 2000a; ). Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol 74, 379–389.[CrossRef]
    [Google Scholar]
  27. Peng, R., Tan, J. & Ling, P. D. ( 2000b; ). Conserved regions in the Epstein–Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol 74, 9953–9963.[CrossRef]
    [Google Scholar]
  28. Rickinson, A. B. & Kieff, E. ( 1996; ). Epstein–Barr virus. In Fields Virology, 3rd edn, pp. 2397–2446. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott–Raven.
    [Google Scholar]
  29. Rickinson, A. B. & Kieff, E. ( 2001; ). Epstein–Barr virus. In Fields Virology, 4th edn, pp. 2575–2627. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
    [Google Scholar]
  30. Sample, J., Hummel, M., Braun, D., Birkenbach, M. & Kieff, E. ( 1986; ). Nucleotide sequences of mRNAs encoding Epstein–Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A 83, 5096–5100.[CrossRef]
    [Google Scholar]
  31. Sladek, R., Bader, J. A. & Giguere, V. ( 1997; ). The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 17, 5400–5409.
    [Google Scholar]
  32. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G. & Wiman, K. G. ( 1993; ). EBNA-5, an Epstein–Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A 90, 5455–5459.[CrossRef]
    [Google Scholar]
  33. Szekely, L., Jiang, W. Q., Pokrovskaja, K., Wiman, K. G., Klein, G. & Ringertz, N. ( 1995; ). Reversible nucleolar translocation of Epstein–Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion. J Gen Virol 76, 2423–2432.[CrossRef]
    [Google Scholar]
  34. Szekely, L., Pokrovskaja, K., Jiang, W. Q., de The, H., Ringertz, N. & Klein, G. ( 1996; ). The Epstein–Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J Virol 70, 2562–2568.
    [Google Scholar]
  35. Tanaka, M., Yokoyama, A., Igarashi, M., Matsuda, G., Kato, K., Kanamori, M., Hirai, K., Kawaguchi, Y. & Yamanashi, Y. ( 2001; ). Conserved region CR2 of Epstein–Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association. J Virol 76, 1025–1032.
    [Google Scholar]
  36. Vanacker, J. M., Bonnelye, E., Delmarre, C. & Laudet, V. ( 1998a; ). Activation of the thyroid hormone receptor alpha gene promoter by the orphan nuclear receptor ERR α. Oncogene 17, 2429–2435.[CrossRef]
    [Google Scholar]
  37. Vanacker, J. M., Delmarre, C., Guo, X. & Laudet, V. ( 1998b; ). Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related α. Cell Growth & Differ 9, 1007–1014.
    [Google Scholar]
  38. Vottero, A., Kirschner, L. S., Yue, W., Brodie, A. & Stratakis, C. A. ( 1998; ). P450arom gene expression in peripheral blood lymphocytes: identification of a cryptic splice site for exon-1 after Epstein–Barr virus transformation. J Steroid Biochem Mol Biol 64, 245–250.[CrossRef]
    [Google Scholar]
  39. Wiley, S. R., Kraus, R. J., Zuo, F., Murray, E. E., Loritz, K. & Mertz, J. E. ( 1993; ). SV40 early-to-late switch involves titration of cellular transcriptional repressors. Genes & Dev 7, 2206–2219.[CrossRef]
    [Google Scholar]
  40. Woisetschlaeger, M., Yandava, C. N., Furmanski, L. A., Strominger, J. L. & Speck, S. H. ( 1990; ). Promoter switching in Epstein–Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci U S A 87, 1725–1729.[CrossRef]
    [Google Scholar]
  41. Woisetschlaeger, M., Jin, X. W., Yandava, C. N., Furmanski, L. A., Strominger, J. L. & Speck, S. H. ( 1991; ). Role for the Epstein–Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc Natl Acad Sci U S A 88, 3942–3946.[CrossRef]
    [Google Scholar]
  42. Yang, N., Shigeta, H., Shi, H. & Teng, C. T. ( 1996; ). Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J Biol Chem 271, 5795–5804.[CrossRef]
    [Google Scholar]
  43. Yang, C., Zhou, D. & Chen, S. ( 1998; ). Modulation of aromatase expression in the breast tissue by ERR1-α orphan receptor. Cancer Res 58, 5695–5700.
    [Google Scholar]
  44. Yokoyama, A., Kawaguchi, Y., Kitabayashi, I., Ohki, M. & Hirai, K. ( 2001a; ). The conserved domain CR2 of Epstein–Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization. Virology 279, 401–413.[CrossRef]
    [Google Scholar]
  45. Yokoyama, A., Tanaka, M., Matsuda, G., Kato, K., Kanamori, M., Kawasaki, H., Hirano, H., Kitabayashi, I., Ohki, M., Hirai, K. & Kawaguchi, Y. ( 2001b; ). Identification of major phosphorylation sites of Epstein–Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. J Virol 75, 5119–5128.[CrossRef]
    [Google Scholar]
  46. Yoo, Y. C., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K. & Azuma, I. ( 1998; ). Bovine lactoferrin and lactoferricin inhibit tumor metastasis in mice. Adv Exp Med Biol 443, 285–291.
    [Google Scholar]
  47. Zhang, Z. & Teng, C. T. ( 2000; ). Estrogen receptor-related receptor α1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275, 20837–20846.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18615-0
Loading
/content/journal/jgv/10.1099/vir.0.18615-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error